BREAKING
Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 6 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 7 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 10 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 11 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 13 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 15 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 17 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 18 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 19 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 19 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 6 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 7 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 10 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 11 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 13 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 15 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 17 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 18 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 19 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 19 hours ago
ADVERTISEMENT
AlphaGraphs

Key highlights from Walgreens Boots Alliance’s (WBA) Q3 2024 earnings results

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported third quarter 2024 earnings results today. Sales increased 2.6% year-over-year to $36.4 billion. Sales rose 2.5% on a constant currency basis. Net earnings were $344 million, or $0.40 per share, compared to $118 million, or $0.14 per share, last year. Adjusted EPS was $0.63, down 36.6% YoY. Revenue […]

$WBA June 27, 2024 1 min read

Walgreens Boots Alliance, Inc. (NASDAQ: WBA) reported third quarter 2024 earnings results today.

Sales increased 2.6% year-over-year to $36.4 billion. Sales rose 2.5% on a constant currency basis.

Net earnings were $344 million, or $0.40 per share, compared to $118 million, or $0.14 per share, last year. Adjusted EPS was $0.63, down 36.6% YoY.

Revenue beat estimates while earnings fell short.

The company is lowering fiscal year 2024 adjusted EPS guidance to $2.80-2.95, reflecting challenging pharmacy industry trends and a worse-than-expected US consumer environment.

ADVERTISEMENT

The stock plunged 15% in premarket hours on Thursday following the announcement.

Prior performance

ADVERTISEMENT